Pharmaceutical Executive
CMS Signals Looming Sunshine Act Audits: How to Prepare
March 1, 2024
New guidance suggests that CMS may be ramping up Sunshine Act auditing activities, potentially resulting in monetary liability for noncompliant reporting entities.
After more than a decade of relative inactivity, the Centers for Medicare & Medicaid Services(CMS) has signaled that it may soon commence audits of reporting entities under the Sunshine Act.
Published by Pharmaceutical Executive on March 1, 2024, available at https://www.pharmexec.com/view/cms-signals-looming-sunshine-act-audits-how-to-prepare.
Contacts
Capabilities
Suggested News & Insights
Sidley Medicaid Drug Rebate Program Summit Cocktail ReceptionMonday, October 5, 2026DOJ Continues to Prioritize Medicare Advantage Enforcement with $22.5 Million SettlementOctober 1, 2026Sidley Represents Jiangsu Hengrui in Connection With US$2.6 Billion Licensing Agreement With Novo NordiskOctober 1, 2026D.C. U.S. Attorney’s Office Announces Creation of Standalone Division Focused on False Claims Act EnforcementSeptember 25, 2026Sidley Healthcare Investment Conference 2026Tuesday, September 22, 2026Sidley Represents Sheridan Capital Partners in Its Investment in PtEverywhereSeptember 22, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

